← All organizations

Staten Biotechnology BV

For profit

Also known as: Staten Biotechnology BV

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Jun 30, 2020

Defunct as of Dec 31, 2025

Timeline

2010s

Jul 1, 2014
Staten Biotechnology BV— Founded

2020s

Dec 31, 2025
Staten Biotechnology BV— Defunct

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

stt-5058

Indications

Studied for

Hypertriglyceridemia

Recent trials (1)

NCT04419688Lead sponsorPhase 1Jun 30, 2020

Details

Founded: Nijmegen, NL Jul 1, 2014
Last known activity: Jun 30, 2020